SMLR - semlerscientific.com Operating income before deduction of amortization

Graphic logo of semlerscientific.com (SMLR)

Risks for Semler Scientific, Inc. (SMLR) depend on the recruitment of qualified engineers and medical representatives to promote medtech. The actual operating profit confirms the business's resilience, where the value of 0.00 serves as the current metric. Software patents ensure stability by creating a monopoly within clinics, while regular purchases of consumables for FloChec systems provide high margins and financial strength.

SMLR Semler Operating profit before deduction of amortization (11/23/2025 - 01/31/2026)

Semler Scientific (SMLR) - metric breakdowns and financial figures

- current price and projected stock value:
Price Semler|SMLR - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Semler Scientific|SMLR - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Semler Scientific|SMLR - Company Net Assets|Market Value to Book Value semlerscientific.com|SMLR - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Semler Scientific, Inc.|SMLR - Long-Term Debt to Capital|Current Liabilities to Capital Semler Scientific Inc|SMLR - Company Aggregate Debts|Debt to Book Value Ratio Semler Scientific|SMLR - Company Long-Term Debts|Short-Term Debt Volume Semler Scientific|Quick Liquidity Indicator semlerscientific.com
- earnings and multiples data:
SMLR - Net Profit|Projected Future Earnings Semler Scientific, Inc.|SMLR - Price to Earnings Ratio|Future Price to Earnings semlerscientific.com|SMLR - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Semler Scientific|SMLR - Operating profit EBITDA|Net earnings per one share for the last twelve months Semler Scientific|SMLR - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year semlerscientific.com|SMLR - Net earnings per share growth this year|Earnings growth forecast for next year Semler Scientific, Inc.
Summary company analytics:Semler - SMLR
Mass-produced product of Semler Scientific, Inc.

This metric measures the net daily cash flow from core operations before depreciation, allowing for an assessment of the business's real operational efficiency. The current value of 0.00 at the base EBITDA level reflects the ability of Semler Scientific, Inc. (SMLR) to convert its aggressive vascular diagnostics sales strategy into liquidity, while extreme growth in this metric may signal market overheating and an impending correction.

Who Semler Scientific, Inc. competes with

Company profit before taxes, interest and amortization ABT (Abbott Corp.)|Thermo Fisher Scientific - Operating profit EBITDA|Operating income before deduction of amortization gehealthcare.com GEHC|MTD: Operating profit EBITDA|Operating profit before deduction of amortization Waters Corp|Operating profit before deduction of amortization TECH|BRKR: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Azenta, Inc. (AZTA)|Operating profit before deduction of amortization vareximaging.com VREX|Operating profit EBITDA BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Profit before interest, taxes and amortization|Quantum-Si Corp - Operating profit EBITDA|NNOX (Nano-X Imaging Ltd) - Operating profit before amortization|QTRX: Operating profit EBITDA|MASS - Operating income before deduction of amortization|CV (CapsoVision, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization MaxCyte Inc. (MXCT)|Operating profit EBITDA RPID|Operating profit EBITDA Seer Bio (SEER)|Profit before payment of interest, taxes and amortization Hyperfine, Inc. HYPR|fonar.com - Profit before payment of interest, taxes and amortization|DXR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization MDAI (spectral-ai.com)|VIVS: Operating profit EBITDA|Profit before interest, taxes and amortization Aclarion Corporation (ACON)|Profit before payment of interest, taxes and amortization Akoya Biosciences Inc|THMO - Operating profit before depreciation charges|Operating profit before deduction of amortization TLIS (Talis Biomedical)|Operating profit EBITDA T2 Biosystems Inc. (TTOO)